Janus Henderson Investors US’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | $118M | Buy |
3,418,861
+26,690
| +0.8% | +$918K | 0.1% | 263 |
|
|
2016
Q4 | $97.8M | Buy |
3,392,171
+195,089
| +6% | +$5.63M | 0.08% | 302 |
|
|
2016
Q3 | $102M | Sell |
3,197,082
-4,533
| -0.1% | -$144K | 0.09% | 299 |
|
|
2016
Q2 | $104M | Buy |
3,201,615
+503,549
| +19% | +$16.3M | 0.09% | 282 |
|
|
2016
Q1 | $75.4M | Buy |
2,698,066
+1,071,819
| +66% | +$30M | 0.07% | 338 |
|
|
2015
Q4 | $58M | Buy |
1,626,247
+6,710
| +0.4% | +$239K | 0.05% | 383 |
|
|
2015
Q3 | $53.6M | Sell |
1,619,537
-1,400,975
| -46% | -$46.3M | 0.05% | 400 |
|
|
2015
Q2 | $126M | Buy |
3,020,512
+206,363
| +7% | +$8.64M | 0.1% | 262 |
|
|
2015
Q1 | $91.7M | Buy |
2,814,149
+160,767
| +6% | +$5.24M | 0.08% | 327 |
|
|
2014
Q4 | $84.2M | Buy |
2,653,382
+40,039
| +2% | +$1.27M | 0.07% | 341 |
|
|
2014
Q3 | $64.7M | Buy |
2,613,343
+1,300,618
| +99% | +$32.2M | 0.06% | 365 |
|
|
2014
Q2 | $29.7M | Buy |
1,312,725
+82,916
| +7% | +$1.87M | 0.03% | 503 |
|
|
2014
Q1 | $29.9M | Buy |
1,229,809
+296,816
| +32% | +$7.22M | 0.03% | 496 |
|
|
2013
Q4 | $23.3M | Buy |
+932,993
| New | +$23.3M | 0.02% | 514 |
|